Muso is taking the delay out of health care | Ari Johnson

Ari Johnson, MD, is co-founder and CEO of Muso, and Associate Professor at the University of California San Francisco, in the Department of Medicine and the Institute for Global Health Sciences. He has published peer-reviewed articles and essays in the fields of infectious disease, health systems design, socioeconomic determinants of health, AIDS, and migration. The co-recipient of the 2021 Charles Bronfman Prize, Ari trained at Harvard Medical School and completed his residency at the University of California San Francisco. Over the past fifteen years, Ari has supported Muso to design and build Rapid Care, a strategy to accelerate universal access to healthcare. A 2018 study in BMJ Global Health documented how communities served by this strategy achieved and sustained a rate of child death lower than any country in Sub-Saharan Africa for five years running. Muso cares for more than 500,000 patients, and supports governments to redesign their national community health systems.